期刊文献+

36例三阴性乳腺癌的临床与病理分析 被引量:3

Clinical and pathological analysis of 36 cases of triple-negative breast cancer
下载PDF
导出
摘要 目的 探讨三阴性乳腺癌的临床病理特点.方法 回顾性分析2006年5月-2010年7月经手术治疗的36例三阴性乳腺癌及同期非三阴性乳腺癌患者资料:发病年龄、肿物大小、病理分期、淋巴结转移情况及雄激素受体的表达,并进行分析比较.结果 三阴性乳腺癌组患者年龄较非三阴性乳腺癌组年轻(χ2=3.861,P〈0.05);三阴性乳腺癌组淋巴结转移、TNM分期与非三阴性乳腺癌组比较差异有统计学意义(χ2分别为4.632、5.016,均P〈0.05);三阴性乳腺癌组雄激素受体阳性表达率低于非三阴性乳腺癌组(χ2=42.960,P〈0.05);三阴性乳腺癌组淋巴结转移率与肿瘤大小差异有统计学意义(χ2=6.076,P〈0.05).结论 三阴性乳腺癌患者年龄较小,临床病理分期较高,淋巴结转移多见,雄激素受体阳性表达率较低,预后差. Objective To investigate the clinical and pathological features of triple-negative breast cancer (TNBC). Methods The data of 36 cases of TNBC and non-triple-negative breast cancer (non-TNBC) treated with operation from May 2006 to July 2010, including age of onset, size of tumor, pathological stage, metastasis of lymph node, and expression of androgen receptor (AR) were retrospectively analyzed and compared. Results The patients with TNBC were younger than those with non-TNBC (X2 = 3. 861, P 〈 0.05 ), and the rate of positive expression of AR in TNBC group was lower than that in non-TNBC group (X2 = 42.960 ,P 〈 0.05 ). The differences in lymph node metastasis and TNM stage were statistically significant between two groups (X2 = 4. 632,5. 016, P 〈 0.05 ). The rate of lymph node metastasis and tumor size were significantly different between two groups (X2 = 6. 076,P 〈 0.05 ). Conclusion TNBC group is featured as younger onset age, higher clinical and pathological stage, more metastasis of lymph node, lower rate of positive expression of AR and poorer prognosis.
出处 《中国妇幼健康研究》 2011年第3期370-372,共3页 Chinese Journal of Woman and Child Health Research
基金 黑龙江省卫生厅科研课题资助项目(2009-443)
关键词 三阴性乳腺癌 非三阴性乳腺癌 雄激素受体 淋巴结转移 triple-negative breast cancer ( TNBC ) non-triple-negative breast cancer ( non-TNBC ) androgen receptor lymph node metastasis
  • 相关文献

参考文献8

  • 1Sorlie T,Perou C,Tibshirani R,et al.Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications[J].Proc Natl Acad Sci USA,2001,98:(18)10869-10874.
  • 2Hanley K,Wang J,Boume P,et al.Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast[J].Hum Pathol,2008,39(3):386-392.
  • 3Gonzalez L O,Corte M D,Junquera S,et al.Expression of androgen receptor and two androgen-induced proteins(apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast[J].Histopathology,2007,50(7):866-874.
  • 4Bauer K R,Brown M,Cress R D,et al.Descriptive analysis of estrogen receptor(ER)-negative,progesterone receptor(PR)-negative,and HER-2-negative invasive breast cancer,the so-called triple-negative phenotype:Apopulation-based study from the California Cancer Registry[J].Cancer,2007,109(9):1721-1728.
  • 5陈晓耕,林志武,柳燕,林镇和.三阴性乳腺癌的临床病理特点及预后因素分析[J].福建医科大学学报,2009,43(2):172-174. 被引量:4
  • 6Doane A S,Danso M,Lal P,et al.An estrogen recptor-negative breast cancer subset characterized by a homonally regulated transcriptional program and response to androgen[J].Oncogene,2006,25(28):3994-4008.
  • 7Rakha E A,El-Sayed M E,Green A R,et al.Prognostic marks intriple-negative breast cancer[J].Cancer,2007,109(1):25-32.
  • 8Dent R, Trudeau M, Pritchard K I, et al. Triple-negative breast cancer :Clinical features and patterns of recurrence[ J ]. Clin Cancer Res,2007,13 ( 15 ) :4429-4434.

二级参考文献11

  • 1Perou C M,Sorlie T,Eisen M B,et al. Molecular portraits of human breast tumours[J]. Nature, 2000,706:747-752.
  • 2Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics[J]. CA Cancer J Clin, 2005,55(2):74-108.
  • 3Bauer K R,Brown M,Cress R D,et al. Descriptive analysis of estrogen receptor(ER)-negative, progesterone receptor (PR)- negative,and HER2-negative invasive breast cancer, the socalled triple-negative phenotype: A population-based study from the California Cancer Registry[J]. Cancer, 2007, 109: 1721-1728.
  • 4Dent R, Trudeau M, Pritehard K I, et al. Triple-negative breast cancer: clinical features and patterns of recurrence[J]. Clin Cancer Res , 2007,13:4429-4434.
  • 5Haffty B G, Yang Q, Reiss M, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer [J]. J Clin Oncol, 2006, 24: 5652-5657.
  • 6Rakha E A, El-Sayed M E,Green A R,et al. Prognostic markers in triple-negative breast cancer[J]. Cancer, 2007, 109: 25-32.
  • 7Tisehkowitz M,Brunet J S,Begin L R,et al. Use of immunohisto-chemieal markers can refine prognosis in triple negative breast cancer[J]. BMC Cancer, 2007,7 : 134.
  • 8Foulkes W D,Metcalfe K, Hanna W,et al. Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma[J]. Cancer, 2003,98:1569-1577.
  • 9杨德宏,刘红,赵晶.三阴型乳腺癌临床病理特征及预后分析[J].中国肿瘤临床,2008,35(9):501-504. 被引量:40
  • 10袁中玉,王树森,高岩,苏争艳,罗文标,管忠震.305例三阴乳腺癌患者的临床特征及预后因素分析[J].癌症,2008,27(6):561-565. 被引量:161

共引文献3

同被引文献13

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部